嚢虫症治療の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Cysticercosis Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D005-00260 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、嚢虫症治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。嚢虫症治療の種類別市場規模（プラジカンテル、アルベンダゾール）、用途別市場規模（病院・診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：GlaxoSmithKline、Pharmaco-Kinesis、Klarsehen India、Amedra Pharmaceuticals、Cipla、Bayer、Taj Pharmaceuticals、Salius、Ranbaxy、Bonaide ・地域別グローバル市場分析 2015年-2020年 ・嚢虫症治療の北米市場（アメリカ、カナダ、メキシコ） ・嚢虫症治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・嚢虫症治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・嚢虫症治療の南米市場（ブラジル、アルゼンチン） ・嚢虫症治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：プラジカンテル、アルベンダゾール ・用途別分析：病院・診療所、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global Cysticercosis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Cysticercosis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Cysticercosis Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Cysticercosis Treatment market has been segmented into:
Praziquantel
Albendazole

By Application, Cysticercosis Treatment has been segmented into:
Hospitals and Clinics
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cysticercosis Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Cysticercosis Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cysticercosis Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Cysticercosis Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Cysticercosis Treatment Market Share Analysis
Cysticercosis Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cysticercosis Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cysticercosis Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Cysticercosis Treatment are:
GlaxoSmithKline
Pharmaco-Kinesis
Klarsehen India
Amedra Pharmaceuticals
Cipla
Bayer
Taj Pharmaceuticals
Salius
Ranbaxy
Bonaide

レポート目次

---

Table of Contents

1 Cysticercosis Treatment Market Overview
1.1 Product Overview and Scope of Cysticercosis Treatment
1.2 Classification of Cysticercosis Treatment by Type
1.2.1 Global Cysticercosis Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cysticercosis Treatment Revenue Market Share by Type in 2019
1.2.3 Praziquantel
1.2.4 Albendazole
1.3 Global Cysticercosis Treatment Market by Application
1.3.1 Overview: Global Cysticercosis Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Global Cysticercosis Treatment Market by Regions
1.4.1 Global Cysticercosis Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cysticercosis Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cysticercosis Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cysticercosis Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cysticercosis Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cysticercosis Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cysticercosis Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Cysticercosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pharmaco-Kinesis
2.2.1 Pharmaco-Kinesis Details
2.2.2 Pharmaco-Kinesis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pharmaco-Kinesis SWOT Analysis
2.2.4 Pharmaco-Kinesis Product and Services
2.2.5 Pharmaco-Kinesis Cysticercosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Klarsehen India
2.3.1 Klarsehen India Details
2.3.2 Klarsehen India Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Klarsehen India SWOT Analysis
2.3.4 Klarsehen India Product and Services
2.3.5 Klarsehen India Cysticercosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Amedra Pharmaceuticals
2.4.1 Amedra Pharmaceuticals Details
2.4.2 Amedra Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Amedra Pharmaceuticals SWOT Analysis
2.4.4 Amedra Pharmaceuticals Product and Services
2.4.5 Amedra Pharmaceuticals Cysticercosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cipla
2.5.1 Cipla Details
2.5.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Cipla SWOT Analysis
2.5.4 Cipla Product and Services
2.5.5 Cipla Cysticercosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bayer SWOT Analysis
2.6.4 Bayer Product and Services
2.6.5 Bayer Cysticercosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Taj Pharmaceuticals
2.7.1 Taj Pharmaceuticals Details
2.7.2 Taj Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Taj Pharmaceuticals SWOT Analysis
2.7.4 Taj Pharmaceuticals Product and Services
2.7.5 Taj Pharmaceuticals Cysticercosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Salius
2.8.1 Salius Details
2.8.2 Salius Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Salius SWOT Analysis
2.8.4 Salius Product and Services
2.8.5 Salius Cysticercosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Ranbaxy
2.9.1 Ranbaxy Details
2.9.2 Ranbaxy Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Ranbaxy SWOT Analysis
2.9.4 Ranbaxy Product and Services
2.9.5 Ranbaxy Cysticercosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bonaide
2.10.1 Bonaide Details
2.10.2 Bonaide Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bonaide SWOT Analysis
2.10.4 Bonaide Product and Services
2.10.5 Bonaide Cysticercosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cysticercosis Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cysticercosis Treatment Players Market Share
3.2.2 Top 10 Cysticercosis Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cysticercosis Treatment Revenue and Market Share by Regions
4.2 North America Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
5 North America Cysticercosis Treatment Revenue by Countries
5.1 North America Cysticercosis Treatment Revenue by Countries (2015-2020)
5.2 USA Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
6 Europe Cysticercosis Treatment Revenue by Countries
6.1 Europe Cysticercosis Treatment Revenue by Countries (2015-2020)
6.2 Germany Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
6.4 France Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cysticercosis Treatment Revenue by Countries
7.1 Asia-Pacific Cysticercosis Treatment Revenue by Countries (2015-2020)
7.2 China Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
7.5 India Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
8 South America Cysticercosis Treatment Revenue by Countries
8.1 South America Cysticercosis Treatment Revenue by Countries (2015-2020)
8.2 Brazil Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cysticercosis Treatment by Countries
9.1 Middle East & Africa Cysticercosis Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cysticercosis Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Cysticercosis Treatment Market Forecast by Type (2019-2024)
10.3 Praziquantel Revenue Growth Rate (2015-2025)
10.4 Albendazole Revenue Growth Rate (2015-2025)
11 Global Cysticercosis Treatment Market Segment by Application
11.1 Global Cysticercosis Treatment Revenue Market Share by Application (2015-2020)
11.2 Cysticercosis Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals and Clinics Revenue Growth (2015-2020)
11.4 Others Revenue Growth (2015-2020)
12 Global Cysticercosis Treatment Market Size Forecast (2021-2025)
12.1 Global Cysticercosis Treatment Market Size Forecast (2021-2025)
12.2 Global Cysticercosis Treatment Market Forecast by Regions (2021-2025)
12.3 North America Cysticercosis Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Cysticercosis Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cysticercosis Treatment Revenue Market Forecast (2021-2025)
12.6 South America Cysticercosis Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cysticercosis Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Cysticercosis Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cysticercosis Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cysticercosis Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cysticercosis Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. GlaxoSmithKline Corporate Information, Location and Competitors
Table 6. GlaxoSmithKline Cysticercosis Treatment Major Business
Table 7. GlaxoSmithKline Cysticercosis Treatment Total Revenue (USD Million) (2017-2018)
Table 8. GlaxoSmithKline SWOT Analysis
Table 9. GlaxoSmithKline Cysticercosis Treatment Product and Solutions
Table 10. GlaxoSmithKline Cysticercosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Pharmaco-Kinesis Corporate Information, Location and Competitors
Table 12. Pharmaco-Kinesis Cysticercosis Treatment Major Business
Table 13. Pharmaco-Kinesis Cysticercosis Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Pharmaco-Kinesis SWOT Analysis
Table 15. Pharmaco-Kinesis Cysticercosis Treatment Product and Solutions
Table 16. Pharmaco-Kinesis Cysticercosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Klarsehen India Corporate Information, Location and Competitors
Table 18. Klarsehen India Cysticercosis Treatment Major Business
Table 19. Klarsehen India Cysticercosis Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Klarsehen India SWOT Analysis
Table 21. Klarsehen India Cysticercosis Treatment Product and Solutions
Table 22. Klarsehen India Cysticercosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Amedra Pharmaceuticals Corporate Information, Location and Competitors
Table 24. Amedra Pharmaceuticals Cysticercosis Treatment Major Business
Table 25. Amedra Pharmaceuticals Cysticercosis Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Amedra Pharmaceuticals SWOT Analysis
Table 27. Amedra Pharmaceuticals Cysticercosis Treatment Product and Solutions
Table 28. Amedra Pharmaceuticals Cysticercosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Cipla Corporate Information, Location and Competitors
Table 30. Cipla Cysticercosis Treatment Major Business
Table 31. Cipla Cysticercosis Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Cipla SWOT Analysis
Table 33. Cipla Cysticercosis Treatment Product and Solutions
Table 34. Cipla Cysticercosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Bayer Corporate Information, Location and Competitors
Table 36. Bayer Cysticercosis Treatment Major Business
Table 37. Bayer Cysticercosis Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Bayer SWOT Analysis
Table 39. Bayer Cysticercosis Treatment Product and Solutions
Table 40. Bayer Cysticercosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Taj Pharmaceuticals Corporate Information, Location and Competitors
Table 42. Taj Pharmaceuticals Cysticercosis Treatment Major Business
Table 43. Taj Pharmaceuticals Cysticercosis Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Taj Pharmaceuticals SWOT Analysis
Table 45. Taj Pharmaceuticals Cysticercosis Treatment Product and Solutions
Table 46. Taj Pharmaceuticals Cysticercosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Salius Corporate Information, Location and Competitors
Table 48. Salius Cysticercosis Treatment Major Business
Table 49. Salius Cysticercosis Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Salius SWOT Analysis
Table 51. Salius Cysticercosis Treatment Product and Solutions
Table 52. Salius Cysticercosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Ranbaxy Corporate Information, Location and Competitors
Table 54. Ranbaxy Cysticercosis Treatment Major Business
Table 55. Ranbaxy Cysticercosis Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Ranbaxy SWOT Analysis
Table 57. Ranbaxy Cysticercosis Treatment Product and Solutions
Table 58. Ranbaxy Cysticercosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Bonaide Corporate Information, Location and Competitors
Table 60. Bonaide Cysticercosis Treatment Major Business
Table 61. Bonaide Cysticercosis Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Bonaide SWOT Analysis
Table 63. Bonaide Cysticercosis Treatment Product and Solutions
Table 64. Bonaide Cysticercosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Cysticercosis Treatment Revenue (Million USD) by Players (2015-2020)
Table 66. Global Cysticercosis Treatment Revenue Share by Players (2015-2020)
Table 67. Global Cysticercosis Treatment Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Cysticercosis Treatment Revenue Market Share by Regions (2015-2020)
Table 69. North America Cysticercosis Treatment Revenue by Countries (2015-2020)
Table 70. North America Cysticercosis Treatment Revenue Market Share by Countries (2015-2020)
Table 71. Europe Cysticercosis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Cysticercosis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Cysticercosis Treatment Revenue by Countries (2015-2020)
Table 74. South America Cysticercosis Treatment Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Cysticercosis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Cysticercosis Treatment Revenue Market Share by Countries (2015-2020)
Table 77. Global Cysticercosis Treatment Revenue (Million USD) by Type (2015-2020)
Table 78. Global Cysticercosis Treatment Revenue Share by Type (2015-2020)
Table 79. Global Cysticercosis Treatment Revenue Forecast by Type (2021-2025)
Table 80. Global Cysticercosis Treatment Revenue by Application (2015-2020)
Table 81. Global Cysticercosis Treatment Revenue Share by Application (2015-2020)
Table 82. Global Cysticercosis Treatment Revenue Forecast by Application (2021-2025)
Table 83. Global Cysticercosis Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cysticercosis Treatment Picture
Figure 2. Global Cysticercosis Treatment Revenue Market Share by Type in 2019
Figure 3. Praziquantel Picture
Figure 4. Albendazole Picture
Figure 5. Cysticercosis Treatment Revenue Market Share by Application in 2019
Figure 6. Hospitals and Clinics Picture
Figure 7. Others Picture
Figure 8. Global Cysticercosis Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Cysticercosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Cysticercosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Cysticercosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Cysticercosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Cysticercosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Cysticercosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Cysticercosis Treatment Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Cysticercosis Treatment Revenue Market Share in 2019
Figure 17. Global Top 10 Players Cysticercosis Treatment Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Cysticercosis Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Cysticercosis Treatment Revenue Market Share by Regions (2015-2020)
Figure 21. Global Cysticercosis Treatment Revenue Market Share by Regions in 2018
Figure 22. North America Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 23. Europe Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 25. South America Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 27. North America Cysticercosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 28. North America Cysticercosis Treatment Revenue Market Share by Countries in 2019
Figure 29. USA Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Canada Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Europe Cysticercosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Cysticercosis Treatment Revenue Market Share by Countries in 2019
Figure 34. Germany Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 35. UK Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 36. France Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 37. Russia Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Italy Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Cysticercosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Cysticercosis Treatment Revenue Market Share by Countries in 2019
Figure 41. China Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Japan Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Korea Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 44. India Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 46. South America Cysticercosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 47. South America Cysticercosis Treatment Revenue Market Share by Countries in 2019
Figure 48. Brazil Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Cysticercosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Cysticercosis Treatment Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 53. UAE Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Cysticercosis Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Global Cysticercosis Treatment Revenue Share by Type (2015-2020)
Figure 57. Global Cysticercosis Treatment Revenue Share by Type in 2019
Figure 58. Global Cysticercosis Treatment Market Share Forecast by Type (2021-2025)
Figure 59. Global Praziquantel Revenue Growth Rate (2015-2020)
Figure 60. Global Albendazole Revenue Growth Rate (2015-2020)
Figure 61. Global Cysticercosis Treatment Revenue Share by Application (2015-2020)
Figure 62. Global Cysticercosis Treatment Revenue Share by Application in 2019
Figure 63. Global Cysticercosis Treatment Market Share Forecast by Application (2021-2025)
Figure 64. Global Hospitals and Clinics Revenue Growth Rate (2015-2020)
Figure 65. Global Others Revenue Growth Rate (2015-2020)
Figure 66. Global Cysticercosis Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Cysticercosis Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Cysticercosis Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Cysticercosis Treatment Revenue Market Forecast (2021-2025)
Figure 70. Europe Cysticercosis Treatment Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Cysticercosis Treatment Revenue Market Forecast (2021-2025)
Figure 72. South America Cysticercosis Treatment Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Cysticercosis Treatment Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel

---